Riyadh, Madrid to Develop Economic Cooperation, Military Industries

Spanish Ambassador to Asharq Al-Awsat: Joint Committee Scheduled to be Held in Spain on October 20

 Spanish Ambassador to Saudi Arabia Jorge Hevia Sierra (Asharq Al-Awsat)
Spanish Ambassador to Saudi Arabia Jorge Hevia Sierra (Asharq Al-Awsat)
TT

Riyadh, Madrid to Develop Economic Cooperation, Military Industries

 Spanish Ambassador to Saudi Arabia Jorge Hevia Sierra (Asharq Al-Awsat)
Spanish Ambassador to Saudi Arabia Jorge Hevia Sierra (Asharq Al-Awsat)

Spanish Ambassador to Saudi Arabia Jorge Hevia Sierra said that his country was seeking to strengthen its strategic partnership with Riyadh, noting that a joint committee was scheduled to be held in Spain on Oct. 20 to review the development of bilateral economic relations.

Speaking to Asharq Al-Awsat, Sierra pointed to the presence of a joint defense committee, which is working on the development of a memorandum of understanding to promote cooperation in this field.

He said that many non-organizational agreements were signed in 2018, including an executive program for cultural cooperation, in addition to a memorandum of understanding on scientific and technological cooperation, and another MOU in the field of labor and social development.

“The joint statement issued on the occasion of the Crown Prince’s visit to Spain in 2018 refers to the strong partnership between our two countries,” Sierra said, stressing that the statement would represent the basis for “advancing our bilateral relations, with a special focus on the contribution that Spain can make in achieving Vision 2030.”

The ambassador emphasized the depth of the special fraternal relationship between the Spanish and Saudi royal families, which in a way frames the good dialogue between the two governments and facilitates the unique nature of the relations between the two cultures.

On areas of cooperation and agreements concluded between the two countries, Sierra said: “Through the General Cooperation Agreement of 2007, our two countries agreed to strengthen friendly relations and historical ties between their citizens, as well as to enhance bilateral cooperation. In this context, a joint committee was established and has met twice so far, in 2014 and 2018.”

He noted that around 80 Spanish companies were present in the Saudi market, covering various sectors, including the military industry, oil and refineries, combined technologies and water infrastructure, construction, infrastructure and consultancy.

Regarding the trade balance, Sierra said that merchandise exports closed last year with an approximate value of 1.9 billion euros (6.9 billion riyals), an increase of nearly 10 percent compared to 2020, while the main exported goods include machinery, mechanical equipment, ceramics and electrical appliances.

Imports, according to the Spanish ambassador, amounted to 2.9 billion euros (10.5 billion riyals), an increase of 30 percent compared to 2020, and covered fuels, in addition to mineral oils, organic chemical products, plastics and their products.

As for the volume of investments, he said that the balance of investments amounted to 483 million euros (1.7 billion riyals) for the year 2020, mainly concentrated in the crude oil and natural gas extraction sector.

The balance of Saudi investments in Spain amounted to 917 million euros (3.3 billion riyals), concentrated mainly in the sectors of oil refining, air transport, and real estate activities.

The ambassador highlighted the Saudi-Spanish cooperation in the military industry, noting that the Kingdom was a strategic partner in the region, as about 30 Spanish companies participated in the last edition of the World Defense Exhibition in Riyadh.

Spanish companies are interested in long-term partnerships in the Saudi market, which is evident through the establishment of joint ventures between SAMI and Airbus, he stated.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.